News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
818,244 Results
Type
Article (56380)
Company Profile (601)
Press Release (761249)
Multimedia
Podcasts (206)
Webinars (33)
Section
Business (226605)
Career Advice (3026)
Deals (39055)
Drug Delivery (173)
Drug Development (88223)
Employer Resources (191)
FDA (18017)
Job Trends (16865)
News (383432)
Policy (37092)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (2859)
Academic (2)
Accelerated approval (58)
ADA (48)
Adcomms (39)
Allergies (209)
Alliances (55355)
ALS (242)
Alzheimer's disease (1974)
Antibody-drug conjugate (ADC) (575)
Approvals (18437)
Artificial intelligence (840)
ASCO (340)
Autoimmune disease (377)
Automation (67)
Bankruptcy (404)
Best Places to Work (12448)
BIO (78)
BIOSECURE Act (23)
Biosimilars (253)
Biotechnology (386)
Bladder cancer (213)
Brain cancer (84)
Breast cancer (849)
Cancer (6703)
Cardiovascular disease (558)
Career advice (2584)
Career pathing (52)
CAR-T (385)
CDC (71)
Celiac Disease (3)
Cell therapy (1069)
Cervical cancer (58)
Clinical research (76730)
Collaboration (2435)
Commercialization (1)
Company closure (8)
Compensation (1579)
Complete response letters (109)
COVID-19 (3001)
CRISPR (127)
C-suite (1354)
Cystic fibrosis (168)
Data (8936)
Decentralized trials (3)
Denatured (70)
Depression (201)
Dermatology (103)
Diabetes (711)
Diagnostics (7563)
Digital health (71)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (421)
Drug pricing (241)
Drug shortages (38)
Duchenne muscular dystrophy (328)
Earnings (99977)
Editorial (80)
Employer branding (24)
Employer resources (170)
Events (135063)
Executive appointments (1219)
FDA (22233)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (1997)
Gene editing (276)
Generative AI (80)
Gene therapy (848)
GLP-1 (1272)
Government (5285)
Grass and pollen (8)
Guidances (425)
Healthcare (20758)
Hematology (197)
HIV (95)
Huntington's disease (69)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (118)
Immunology and inflammation (356)
Immuno-oncology (119)
Indications (225)
Infectious disease (3395)
Inflammatory bowel disease (244)
Inflation Reduction Act (16)
Influenza (151)
Intellectual property (331)
Interviews (568)
IPO (17853)
IRA (58)
Job creations (4768)
Job search strategy (2104)
JPM (71)
Kidney cancer (23)
Labor market (117)
Layoffs (684)
Leadership (52)
Legal (9364)
Liver cancer (109)
Longevity (37)
Lung cancer (878)
Lymphoma (490)
Machine learning (69)
Management (67)
Manufacturing (1264)
Marketing (5)
MASH (229)
Medical affairs (1)
Medical device (15140)
Medtech (15326)
Mergers & acquisitions (22554)
Metabolic disorders (1833)
mRNA (271)
Multiple sclerosis (210)
NASH (22)
Neurodegenerative disease (522)
Neuropsychiatric disorders (127)
Neuroscience (3763)
Neurotech (1)
NextGen: Class of 2026 (7402)
Non-profit (4896)
Now hiring (84)
Obesity (866)
Opinion (374)
Ovarian cancer (251)
Pain (284)
Pancreatic cancer (374)
Parkinson's disease (425)
Partnered (40)
Patents (673)
Patient recruitment (819)
Peanut (72)
People (66250)
Pharmaceutical (95)
Pharmacy benefit managers (38)
Phase 1 (23872)
Phase 2 (33644)
Phase 3 (25219)
Pipeline (10274)
Policy (389)
Postmarket research (2910)
Preclinical (10274)
Press Release (71)
Prostate cancer (353)
Psychedelics (73)
Radiopharmaceuticals (376)
Rare diseases (1319)
Real estate (6950)
Recruiting (79)
Regulatory (28735)
Reports (63)
Research institute (2630)
Resumes & cover letters (474)
Rett syndrome (47)
RNA editing (29)
RSV (100)
Schizophrenia (198)
Series A (344)
Series B (251)
Service/supplier (20)
Sickle cell disease (133)
Special edition (32)
Spinal muscular atrophy (183)
Sponsored (53)
Startups (4230)
State (2)
Stomach cancer (21)
Supply chain (149)
Tariffs (104)
The Weekly (133)
Vaccines (1304)
Venture capital (140)
Weight loss (585)
Women's health (145)
Worklife (25)
Date
Today (152)
Last 7 days (478)
Last 30 days (2357)
Last 365 days (32653)
2026 (17716)
2025 (32321)
2024 (37537)
2023 (42385)
2022 (53741)
2021 (58465)
2020 (57167)
2019 (50363)
2018 (38243)
2017 (35722)
2016 (36010)
2015 (42057)
2014 (36420)
2013 (31754)
2012 (33575)
2011 (33842)
2010 (32208)
Location
Africa (988)
Alabama (102)
Alaska (7)
Arizona (392)
Arkansas (16)
Asia (47686)
Australia (7957)
California (14622)
Canada (4094)
China (1632)
Colorado (631)
Connecticut (646)
Delaware (451)
Europe (107106)
Florida (2194)
Georgia (468)
Hawaii (4)
Idaho (67)
Illinois (1241)
India (108)
Indiana (668)
Iowa (26)
Japan (623)
Kansas (142)
Kentucky (56)
Louisiana (63)
Maine (89)
Maryland (1757)
Massachusetts (10707)
Michigan (415)
Minnesota (811)
Mississippi (6)
Missouri (163)
Montana (36)
Nebraska (31)
Nevada (158)
New Hampshire (92)
New Jersey (3878)
New Mexico (35)
New York (3857)
North Carolina (1943)
North Dakota (11)
Northern California (7320)
Ohio (455)
Oklahoma (26)
Oregon (50)
Pennsylvania (2868)
Puerto Rico (33)
Rhode Island (55)
South America (1401)
South Carolina (90)
South Dakota (2)
Southern California (5769)
Tennessee (238)
Texas (2374)
United States (52158)
Utah (439)
Vermont (2)
Virginia (375)
Washington D.C. (89)
Washington State (1186)
West Virginia (4)
Wisconsin (157)
Wyoming (2)
818,244 Results for "johnson and johnson consumer companies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform
June 8, 2026
·
5 min read
Press Releases
CHMP recommendation advances Johnson & Johnson’s TECVAYLI®▼ (teclistamab) plus daratumumab as a potential standard of care for relapsed/refractory multiple myeloma
June 26, 2026
·
17 min read
Press Releases
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results 2026
May 28, 2026
·
1 min read
Press Releases
Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida
June 15, 2026
·
6 min read
Press Releases
Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients
June 11, 2026
·
17 min read
Press Releases
John Slump Launches Metis MedTech Following Atraverse Medical Acquisition by Johnson & Johnson
May 28, 2026
·
2 min read
Press Releases
Johnson & Johnson presents new data further reinforcing the role of nipocalimab in lowering the autoantibodies driving Sjögren’s disease
June 3, 2026
·
12 min read
Press Releases
Johnson & Johnson presents new IMAAVY®▼ (nipocalimab) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalised myasthenia gravis
June 28, 2026
·
20 min read
Press Releases
Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis
June 28, 2026
·
21 min read
Press Releases
Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study
June 3, 2026
·
15 min read
1 of 81,825
Next
